Mylan Loses Fight For Generic Hypertension Drug
Dealing a blow to generic drug maker Mylan Laboratories Inc., a federal judge in Pennsylvania has upheld Pfizer Inc.'s patent covering the key ingredient in its popular hypertension drug, Norvasc....To view the full article, register now.
Already a subscriber? Click here to view full article